According to a report published by Grand View Research, Inc.; the In-Situ Hybridization (ISH) market is expected to reach a valuation of around USD 1.84 billion by 2025.
Increasing prevalence of chronic diseases such as cancer along with demand for rapid diagnostic techniques can propel the market during the forecast period (2014 to 2025). In addition, increasing occurrence of genetic disorders, leukemia, solid tumors, autism, and other conditions can support the market growth.
Growing demand for molecular diagnostic tools in clinical research and diagnosis is likely to increase demand for ISH in the years to come. Introduction of real-time and automated diagnostic kits for accurate and rapid diagnosis of cytogenetic modifications is also expected to create positive outlook for the market. Development of advanced probe-based technologies are also supporting the market growth. For instance, Silver ISH (SISH) assay technology, a type of Chromogenic ISH (CISH), is one of the emerging technologies in the market. In addition, growing R&D related to application of ISH in genetic diseases and testing of infectious diseases is anticipated to fuel the market growth in the coming years.
Full Research Report On In Situ Hybridization (ISH) Market Analysis: https://www.grandviewresearch.com/industry-analysis/in-situ-hybridization-ish-market
Worldwide In-Situ Hybridization (ISH) market can be segmented on the basis of type, technology, product, application, end-use, and region. Based on type, the market can be categorized into DNA and RNA. The DNA segment held for the major share due to its high adoption in clinical research and diagnosis of diseases caused due to bacteria. The RNA probes segment is likely to exhibit lucrative CAGR in the coming years owing to its low cost and high stability. As per, technology, the market can be characterized into fluorescent In-Situ Hybridization (FISH) and chromogenic In-Situ Hybridization (CISH). In 2016, the FISH estimated for the largest market share in terms of revenue due to its increasing use in molecular diagnostics.
On the basis of product, the market split into instruments, kits and probes, software, and services. As per application, the market can be fragmented into cancer, developmental biology, cytogenetics, infectious diseases, and others.
View More Reports Of This Category By Grand View Research At: https://www.grandviewresearch.com/industry/biotechnology
In 2016, instruments accounted for the largest share due to increasing demand from diagnostic and research laboratories as it provides several advantages including portability, easy to use, and cost-efficiency. The kits and probes segment is likely to display a lucrative CAGR during the forecast period. Growing cases of target diseases like cancer is likely to increase demand for these products. The service segment is anticipated to exhibit high growth during the forecast period due to rise in outsourcing of molecular biology services among the researchers and pathologists.
Based on end-use, the market classified into research and diagnostic laboratories, contract research organizations (CROs), academic institutes, and others. In 2016, the research and diagnostic laboratories segment estimated for the major share due to rise in applications of molecular cytogenetics in diagnostics. The Contract Research Organizations (CROs) segment is likely to show lucrative gains in the years to come due to growing trend of outsourcing molecular biology services.
Geographically, the market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. IN 2016, North America estimated for the largest market share due to high expenditure for research and government effort for development of novel diagnostic tools.
Europe represents the second-largest market. Growth in this region can be attributed to existence of government organizations like European Diagnostic Manufacturers Association (EDMA), which emphasizes on development of IVD industry in the region.
Asia Pacific is projected to display lucrative CAGR in the years to come. This growth can be associated with growing government investment to support research in molecular biology and increasing awareness among the researchers regarding benefits of ISH technology in diagnostics.
Prominent companies operating in the market include Bio-Rad Laboratories, Inc.; PerkinElmer, Inc.; NeoGenomics Laboratories, Inc.; Oxford Gene Technology.; and Thermo Fisher Scientific.
The market is extremely competitive, and some companies are dominating the due to their extensive product range and geographic reach across the world. Participants are concentrating more on enhancement of distribution channel and operational reformation.
Explore the BI enabled intuitive market research database, The Grand Library, by Grand View Research, Inc.
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com
Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist - U.S.A.
Email:Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
State: California
Country: United States
Website: www.grandviewresearch.com/industry-analysis/in-situ-hybridization-ish-market
